Start Time: 16:30
End Time: 18:01
Biolase, Inc. (BIOL)
Q2 2012 Earnings CallAugust 8, 2012 04:30 p.m. ET Executives Matt Clawson – IR, Allen & Caron Federico Pignatelli – Chairman & CEO Fred Furry – COO & CFO Analysts Dalton Chandler – Needham & Co Greg Garner – Singular Research Chris Sassouni – Eagle Asset Management Lenny Brecken – Brecken Capital Presentation Operator
» Advanced Cell Technology's CEO Discusses Q2 2012 Results - Earnings Call Transcript
» MannKind's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Thank you, Kelly. Good afternoon everyone and thank you all for joining us today for BIOLASE’s 2012 second quarter and six months results conference call. You should have all received a copy by e-mail this morning of the release announcing the company’s results for the second quarter and six months ended June 30, 2012. Before we get started, I’ve been asked to make the following statements. The words and phrases can be, may affect, may depend, believe, estimate, project and similar words and phrases are intended to identify forward-looking statements. Forward-looking statements are subject to various known and unknown risks and uncertainties and BIOLASE cautions you that any forward-looking information provided is not a guarantee of future performance. Actual results could differ materially from these anticipated in the forward-looking statements due to a number of factors, some of which are beyond BIOLASE’s control and may be discussed in BIOLASE’s filings with the Securities and Exchange Commission. All such forward-looking statements are current only as of the date on which statements are made.